(Q34750109)

4 August 2017

title

A single dose of zafirlukast reduces LTD4-induced bronchoconstriction in patients on maintenance inhaled corticosteroid therapy (English)

1 reference

4 August 2017

1 reference

L J Smith

1

1 reference

4 August 2017

L A Hanby

series ordinal

2

1 reference

4 August 2017

B J Lavins

series ordinal

3

1 reference

4 August 2017

S G Simonson

series ordinal

4

1 reference

4 August 2017

publication date

1 July 1998

1 reference

Annals of Allergy, Asthma & Immunology

4 August 2017

published in

1 reference

4 August 2017

volume

81

1 reference

4 August 2017

issue

1

1 reference

4 August 2017

page(s)

43-49

1 reference

Leukotrienes and airway responses.

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963108-0

7 January 2021

Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963108-0

7 January 2021

Leukotrienes and lipoxins: structures, biosynthesis, and biological effects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963108-0

7 January 2021

Airway constriction in normal humans produced by inhalation of leukotriene D. Potency, time course, and effect of aspirin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963108-0

7 January 2021

The effects of inhaled leukotriene E4 on the airway responsiveness to histamine in subjects with asthma and normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963108-0

7 January 2021

Effects of inhaled leukotriene D4 and platelet-activating factor on airway reactivity in normal subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963108-0

7 January 2021

Release of leukotrienes in patients with bronchial asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963108-0

7 January 2021

Urinary Excretion of Leukotriene E4and 11-dehydro-Thromboxane B2in Response to Bronchial Provocations with Allergen, Aspirin, Leukotriene D4, and Histamine in Asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963108-0

7 January 2021

The preclinical pharmacology of ICI 204,219. A peptide leukotriene antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963108-0

7 January 2021

Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963108-0

7 January 2021

Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963108-0

7 January 2021

Lung function improvement in asthma with a cysteinylleukotriene receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963108-0

7 January 2021

Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963108-0

7 January 2021

Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. The Zafirlukast Trialists Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963108-0

7 January 2021

Inhibition of leukotriene D4-induced bronchoconstriction in subjects with asthma: a concentration-effect study of ICI 204,219.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963108-0

7 January 2021

The effect of inhaled budesonide on the maximal degree of airway narrowing to leukotriene D4 and methacholine in normal subjects in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963108-0

7 January 2021

Standardization of Spirometry, 1994 Update. American Thoracic Society

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963108-0

7 January 2021

Determination of zafirlukast, a selective leukotriene antagonist, human plasma by normal-phase high-performance liquid chromatography with fluorescence detection

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963108-0

7 January 2021

Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963108-0

7 January 2021

Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD4) receptor antagonist, in patients with chronic asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963108-0

7 January 2021

Mechanisms of action of glucocorticoids in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963108-0

7 January 2021

Dexamethasone increases expression of 5-lipoxygenase and its activating protein in human monocytes and THP-1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963108-0

7 January 2021

Effect of oral prednisone on airway inflammatory mediators in atopic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963108-0

7 January 2021

Inhibition of eicosanoid biosynthesis by glucocorticoids in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963108-0

7 January 2021

10.1016/S1081-1206(10)63108-0

Identifiers

DOI

1 reference

4 August 2017

1 reference